Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NIH Announces New Program in Metabolomics

Published: Friday, September 21, 2012
Last Updated: Friday, September 21, 2012
Bookmark and Share
The National Institutes of Health will invest $14.3 million this year with the potential to invest more than $51.4 million over five years.

The sum of all metabolites at any given moment — the metabolome — is a form of chemical readout of the state of health of the cell or body, and provides a wealth of information about nutrition, infection, health, and disease status. Metabolomics technologies have the potential to measure hundreds to thousands of unique metabolites, which can change as the result of disease, environmental exposures, or nutrition. In a clinical setting, metabolomics technologies can be powerful tools for diagnosis and disease follow-up. In basic research, these technologies will transform the ability of investigators to define the mechanisms underlying disease and to develop new strategies for treatment.

The NIH Common Fund is taking a comprehensive approach to increasing the research capacity in metabolomics by funding a variety of initiatives in this area, including training, technology development, standards synthesis, and data sharing capability for this new field.

"We are excited about the potential advances in technology that will enable metabolomics analysis to be conducted in basic and clinical settings, resulting in the discovery of new diagnostic tools and yielding important clues about disease mechanisms. The new cross-cutting metabolomics initiatives will allow for better data sharing and coordination of metabolomics efforts both nationally and internationally," said James M. Anderson, M.D., Ph.D., director of the NIH Division of Program Coordination, Planning and Strategic Initiatives, which oversees trans-NIH program areas, including those supported through the NIH Common Fund.

Three Regional Comprehensive Metabolomics Resource Cores have been awarded from the first round of applications, with the potential to award 2-3 additional at a later date. NIH will invest over $7 million this year in the first three centers, with plans to invest over $28 million over five years. The Regional Comprehensive Metabolomics Resource Cores will increase the national capacity to provide metabolomics profiling and data analysis services to investigators.

The University of Michigan's resource core is a fully integrated program that will provide researchers nationwide with the expertise and infrastructure for metabolomics in addition to training opportunities. The principal investigator of the grant is Dr. Charles Burant who is experienced in metabolomics, diabetes, and obesity research. He is assisted by Dr. Stephen Brown as a program coordinator on day-to-day operations.

University of California, Davis's resource core will serve clinical and biomedical researchers across the West Coast, with access to cutting-edge tools, collaborations and interpretation of data. The leader of this effort is Dr. Oliver Fiehn, who is experienced in metabolomics technologies and databases. He is assisted by Dr. William Wikoff as program coordinator.

The third award goes to Research Triangle Institute in Research Triangle Park, N.C., which is positioned as a leader of regional metabolomics center and offers a comprehensive range of services and collaborative opportunities for metabolomics technologies. The principal investigator of the grant is Dr. Susan Sumner, who has extensive experience and expertise in metabolomics technologies. She is assisted by Dr. Jason Burgess as program coordinator.

In addition to these three comprehensive metabolomics cores awards, a data repository and Coordination Center (DRCC) is also being awarded to the University of California, San Diego. NIH will invest $2 million this year in DRCC and potentially invest $6 million over five years. The DRCC will provide necessary organization and present all data from the cores and other metabolomics efforts to the biomedical research community. The DRCC functions as a coordinating hub so that the awardees can function as a consortium. Dr. Shankar Subramaniam, who has extensive experience in integration of omics data and has experience coordinating other large scale projects, leads the effort at UCSD. All awardees operate as cooperative agreements with NIH and collectively function as a consortium and lead collaborative activities related to metabolomics.

The NIH Common Fund is also supporting efforts in the following areas of metabolomics research and training.

  • Technology Development to Enable Large Scale Metabolomics Analyses (R01 RFA-RM-11-019)
  • Development of Courses or Workshops in Metabolomics (R25 RFA-RM-11-018)
  • Mentored Research Scientist Development Award in Metabolomics (K01 RFA-RM-11-017)
  • Administrative Supplements for Collaborative Activities to Promote Metabolomics Research (NOT-RM-11-024)

For more information about the funded awards, go to: 

Additional information about the Metabolomics Program is available at 




Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Newly Discovered Cells Restore Liver Damage in Mice Without Cancer Risk
The liver is unique among organs in its ability to regenerate after being damaged. Exactly how it repairs itself remained a mystery until recently, when researchers supported by the NIH discovered a type of cell in mice essential to the process
Monday, August 17, 2015
Study Finds Cutting Dietary Fat Reduces Body Fat More than Cutting Carbs
In a recent study, restricting dietary fat led to body fat loss at a rate 68 percent higher than cutting the same number of carbohydrate calories when adults with obesity ate strictly controlled diets.
Friday, August 14, 2015
Inappropriate Medical Food Use in Managing Patients with a Type of Metabolic Disorder
Researchers have proposed that there is a need for more rigorous clinical study of dietary management practices for patients with IEMs, including any associated long-term side effects, which may in turn result in the need to reformulate some medical foods.
Friday, August 14, 2015
Ease of Weight Loss Influenced by Individual Biology
NIH study finds varied responses to calorie restriction in obese adults.
Tuesday, May 12, 2015
Molecule Hijacks Enzyme To Boost Alcohol Metabolism
Study could lead to treatments for people with impaired acetaldehyde metabolism.
Tuesday, February 24, 2015
Underlying Genetics and Marker For Stroke Discovered
NIH-funded findings point to new potential strategies for disease prevention, treatment.
Friday, March 21, 2014
Metabolomics: Taking Aim at Diabetic Kidney Failure
Krolewski and his Joslin colleagues search for better ways of predicting which diabetic people are at risk for ESRD.
Saturday, February 08, 2014
Speeding Validation of Disease Targets
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
Tuesday, February 04, 2014
Study to Examine if Vitamin D Prevents Diabetes
NIH-funded research will test the much-touted vitamin in people with prediabetes.
Monday, October 21, 2013
NIH Researchers Find Diabetes Drug Extends Health and Lifespan in Mice
Study was published in the July 30, 2013 issue of Nature Communications.
Thursday, September 05, 2013
Endocannabinoids Trigger Inflammation That Leads to Diabetes
NIH scientists identify possible treatment target for type 2 diabetes.
Thursday, August 22, 2013
Possible Treatment Target for Type 2 Diabetes Identified
Researchers at the NIH have clarified in rodent and test tube experiments the role that inflammation plays in type 2 diabetes, revealing a possible molecular target for treating the disease.
Tuesday, August 20, 2013
Diabetes Drug Extends Health and Lifespan in Mice
Long-term treatment with the type 2 diabetes drug metformin improves health and longevity of male mice when started at middle age.
Wednesday, July 31, 2013
Scientists Identify Molecular Link between Metabolism and Breast Cancer
A protein associated with conditions of metabolic imbalance, such as diabetes and obesity, may play a role in the development of aggressive forms of breast cancer.
Wednesday, February 06, 2013
U.S. and India Sign Joint Statement
The statement provides greater opportunities for collaborative projects ranging from research to identify genes for diabetes to bettering public health efforts to manage and treat of diabetes.
Friday, June 22, 2012
Scientific News
New ACE-inhibiting Molecule Found in the Asparagus
Scientists have determined that sulfur-containing compounds in plants can inhibit ACE.
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Shedding Light On Century-Old Biochemical Mystery
Yale scientists have used magnetic resonance measurements to show how glucose is metabolized in yeast to answer the puzzle of the “Warburg Effect.”
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Metabolon and BCM Show Metabolomics May Play Key Role in Precision Medicine
Metabolon’s technology enhances understanding of genetic data and improves health assessment in newly published study.
Newly Discovered Cells Restore Liver Damage in Mice Without Cancer Risk
The liver is unique among organs in its ability to regenerate after being damaged. Exactly how it repairs itself remained a mystery until recently, when researchers supported by the NIH discovered a type of cell in mice essential to the process
Study Finds Cutting Dietary Fat Reduces Body Fat More than Cutting Carbs
In a recent study, restricting dietary fat led to body fat loss at a rate 68 percent higher than cutting the same number of carbohydrate calories when adults with obesity ate strictly controlled diets.
Inappropriate Medical Food Use in Managing Patients with a Type of Metabolic Disorder
Researchers have proposed that there is a need for more rigorous clinical study of dietary management practices for patients with IEMs, including any associated long-term side effects, which may in turn result in the need to reformulate some medical foods.
Medical Researchers a Step Closer to Developing Anti-Obesity Pill
A weight loss pill could soon be possible thanks to the work of Deakin University medical researchers.
Engineered Bacterium Produces Important Industrial Chemical
A Korean research team has reported the production of 1,3-diaminopropane via fermentation of an engineered bacterium.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!